212 results on '"Tirado, Oscar M."'
Search Results
2. SPARC-mediated long-term retention of nab-paclitaxel in pediatric sarcomas
3. Sarcoma classification by DNA methylation profiling
4. Metastasis Assessment in Ewing Sarcoma Using Orthotopic Xenografts
5. DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1
6. Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations
7. DNA methylation-based reclassification of olfactory neuroblastoma
8. Abstract 1299: Transcriptomic analysis to unveil alveolar rhabdomyosarcoma metastatic process
9. Data from PCPH/ENTPD5 Expression Confers to Prostate Cancer Cells Resistance against Cisplatin-Induced Apoptosis through Protein Kinase Cα–Mediated Bcl-2 Stabilization
10. Data from Suppression of Deacetylase SIRT1 Mediates Tumor-Suppressive NOTCH Response and Offers a Novel Treatment Option in Metastatic Ewing Sarcoma
11. Supplementary Figure 4 from Meriolins, a New Class of Cell Death–Inducing Kinase Inhibitors with Enhanced Selectivity for Cyclin-Dependent Kinases
12. Data from 2-Deoxyglucose Induces Noxa-Dependent Apoptosis in Alveolar Rhabdomyosarcoma
13. Methods and Materials, Figure 4 Legend from Meriolins, a New Class of Cell Death–Inducing Kinase Inhibitors with Enhanced Selectivity for Cyclin-Dependent Kinases
14. Supplementary Methods, Figure and Table Legends from Caveolin-1 (CAV1) Is a Target of EWS/FLI-1 and a Key Determinant of the Oncogenic Phenotype and Tumorigenicity of Ewing's Sarcoma Cells
15. Data from Meriolins, a New Class of Cell Death–Inducing Kinase Inhibitors with Enhanced Selectivity for Cyclin-Dependent Kinases
16. Supplementary Figures S1-S5 from Suppression of Deacetylase SIRT1 Mediates Tumor-Suppressive NOTCH Response and Offers a Novel Treatment Option in Metastatic Ewing Sarcoma
17. Supplementary Table 1 from Caveolin-1 (CAV1) Is a Target of EWS/FLI-1 and a Key Determinant of the Oncogenic Phenotype and Tumorigenicity of Ewing's Sarcoma Cells
18. Supplementary Figures 1-4 from Caveolin-1 (CAV1) Is a Target of EWS/FLI-1 and a Key Determinant of the Oncogenic Phenotype and Tumorigenicity of Ewing's Sarcoma Cells
19. Supplementary Table 2 from Caveolin-1 (CAV1) Is a Target of EWS/FLI-1 and a Key Determinant of the Oncogenic Phenotype and Tumorigenicity of Ewing's Sarcoma Cells
20. Supplementary Methods from 2-Deoxyglucose Induces Noxa-Dependent Apoptosis in Alveolar Rhabdomyosarcoma
21. Supplementary Materials and Figures 1-3 from PCPH/ENTPD5 Expression Confers to Prostate Cancer Cells Resistance against Cisplatin-Induced Apoptosis through Protein Kinase Cα–Mediated Bcl-2 Stabilization
22. Data from Caveolin-1 (CAV1) Is a Target of EWS/FLI-1 and a Key Determinant of the Oncogenic Phenotype and Tumorigenicity of Ewing's Sarcoma Cells
23. Supplementary Figures 1-6 from 2-Deoxyglucose Induces Noxa-Dependent Apoptosis in Alveolar Rhabdomyosarcoma
24. Low Bcl-2 is a robust biomarker of sensitivity to nab-paclitaxel in Ewing sarcoma
25. The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition
26. Bcl-xL inhibition enhances Dinaciclib-induced cell death in soft-tissue sarcomas
27. Abstract 2501: Identification and characterization of key players in the Ewing Sarcoma metastatic process
28. Novel Targeting of DNA Methyltransferase Activity Inhibits Ewing Sarcoma Cell Proliferation and Enhances Tumor Cell Sensitivity to DNA Damaging Drugs by Activating the DNA Damage Response
29. Correction to: DNA methylation-based reclassification of olfactory neuroblastoma
30. Sirolimus plus gemcitabine: a new therapeutic combination for resistant sarcomas?
31. Rapamycin induces apoptosis of JN-DSRCT-1 cells by increasing the Bax : Bcl-xL ratio through concurrent mechanisms dependent and independent of its mTOR inhibitory activity
32. Rapamycin induces the fusion-type independent downregulation of the EWS/FLI-1 proteins and inhibits Ewing's sarcoma cell proliferation
33. Targeting EWS/FLI1 Driven Signaling Pathways as Therapy for Tumors of the Ewing’s Sarcoma Family
34. LOXL2 promotes oncogenic progression in alveolar rhabdomyosarcoma independently of its catalytic activity
35. Exosomes in Bone Sarcomas: Key Players in Metastasis
36. Caveolin-1 promotes resistance to chemotherapy-induced apoptosis in Ewingʼs sarcoma cells by modulating PKCα phosphorylation
37. The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent inhibition of let-7 miRNAs
38. [13] Laser capture microdissection to assess development
39. Meiotic Arrest and Germ Cell Apoptosis in Androgen-Binding Protein Transgenic Mice*
40. EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma
41. Targeting fusion proteins: a double edge sword?
42. Bcl-xL inhibition enhances Dinaciclib-induced cell death in soft-tissue sarcomas
43. The combination of epigenetic drugs SAHA and HCI-2509 synergistically inhibits EWS-FLI1 and tumor growth in Ewing sarcoma
44. EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma
45. Abstract B22: Uncovering the role of lysyl oxidase-like 2 in rhabdomyosarcoma
46. Abstract B19: Tumor-suppressive activities associated to MIR10A-5p expression in developmental sarcomas
47. DNA methylation profiling opens a new phase in the search of targeted therapy against Ewing sarcoma
48. Correction: The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
49. Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway
50. RING1B contributes to Ewing sarcoma development by repressing the NaV1.6 sodium channel and the NF-κB pathway, independently of the fusion oncoprotein
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.